[Breaking] MFDS Preparing to Introduce 'Remdesivir' Domestically... Clinical Results Positive
[Asia Economy Reporter Kim Suwan] The Ministry of Food and Drug Safety announced on the 29th that it is preparing to introduce 'Remdesivir,' a new drug for the novel coronavirus infection (COVID-19) developed by the multinational pharmaceutical company Gilead, into South Korea.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
At a regular briefing that morning, Lee Eui-kyung, the head of the Ministry of Food and Drug Safety, stated, "Remdesivir is undergoing clinical trials in both the United States and South Korea," and added, "Since the clinical results so far have been positive, we are preparing for its introduction domestically."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
